Survival Analysis of Clear Cell Renal Carcinoma According to the Charlson Comorbidity Index

Journal of Urology

Volumn 179, Issue 3, 2008, Pages 857-861

  Santos Arrontes, Daniel ^a   Fernández Aceñero, María Jesús ^a   García González, Jesús Isidoro ^a   Martín Muñoz, Manuel ^a   Paniagua Andrés, Pedro ^a  

^a HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

carcinoma; comorbidity; kidney; mortality; renal cell

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; CHI SQUARE TEST; COMPUTER PROGRAM; ELECTIVE SURGERY; FEMALE; FISHER EXACT TEST; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COMORBIDITY; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 38849162220     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.10.048     Document Type: Article

References (13)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 106
2. La Vecchia C., Negri E., and Levi F. Increasing incidence of renal cell cancer. JAMA 282 (1999) 2120
3. Surveillance, Epidemiology and End Results Program of the National Cancer Institute from 1975 to 2001. www.seer.cancer.gov Accessed May 2007
4. Kouba E., Smith A., McRackan D., Wallen E.M., and Pruthi R.S. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol 177 (2007) 446
5. Kunkle D.A., Crispen P.L., Li T., and Uzzo R.G. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol 177 (2007) 1692
6. Hall S.F. A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol 59 (2006) 849
7. AJCC Cancer Staging Manual. 6th edition (2002), Springer, New York 323-325
8. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumours (2002), International Union Against Cancer, Geneva
9. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373
10. Leslie J.A., Prihoda T., and Thompson I.M. Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomes. Urol Oncol 21 (2003) 39
11. Gettman M., Boelter C.W., Cheville J.C., Zincke H., Bryant S.C., and Blute M.L. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol 169 (2003) 1282
12. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Helsinki 1964. World Medical Association. http://www.wma.net/e/policy/pdf/17c.pdf Accessed March 3, 2007
13. Nelson E.C., Evans C.P., and Lara P.N. Renal cell carcinoma: current status and emerging therapies. Cancer Treat Review 33 (2007) 299